Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough

Needham analyst Mike Matson upgraded Inogen, Inc INGN from Hold to Buy, with a price forecast of 82.3 million, an increase of 5.5% from the prior-year period, or 7.1% at constant currency rates, due to higher demand from international and domestic business-to-business customers.Matson highlighted the turnaround efforts led by the company’s new management team, which remains underappreciated by the market.Also Read ...